GSK still suffering from Avandia concerns

FTSE 100 movers:

LONDON (ShareCast) - Negative comments in the press and recent concerns about its diabetes drug Avandia continue to plague drug major Glaxo, dropping its shares to their lowest in two years.

All together now - AWWWWWWWWWWWWWWWWWWWWWWWWWWW